PDB26 COMPARATIVE EVALUATION OF THE LONG-TERM COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 AND INSULIN GLARGINE IN A SUB-POPULATION OF POORLY CONTROLLED PATIENTS WITH TYPE-2 DIABETES RECEIVING ORAL ANTIDIABETIC AGENTS
Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67645-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)67645-0/fulltext
Section Title :
Section Order :
227
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67645-0&doi=10.1016/S1098-3015(10)67645-0